Heather Magnan

755 total citations
25 papers, 422 citations indexed

About

Heather Magnan is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Heather Magnan has authored 25 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 8 papers in Cardiology and Cardiovascular Medicine and 6 papers in Surgery. Recurrent topics in Heather Magnan's work include Sarcoma Diagnosis and Treatment (20 papers), Cardiac tumors and thrombi (8 papers) and Vascular Tumors and Angiosarcomas (3 papers). Heather Magnan is often cited by papers focused on Sarcoma Diagnosis and Treatment (20 papers), Cardiac tumors and thrombi (8 papers) and Vascular Tumors and Angiosarcomas (3 papers). Heather Magnan collaborates with scholars based in United States, Italy and France. Heather Magnan's co-authors include Michael P. LaQuaglia, Alexander J. Chou, Paul A. Meyers, Suzanne L. Wolden, Leonard H. Wexler, Shakeel Modak, Anita P. Price, Brian H. Kushner, Dana L. Casey and Kaled M. Alektiar and has published in prestigious journals such as Blood, Cancer and Clinical Cancer Research.

In The Last Decade

Heather Magnan

25 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heather Magnan United States 14 331 122 105 92 89 25 422
Fazilet Öner Dinçbaş Türkiye 12 229 0.7× 126 1.0× 168 1.6× 120 1.3× 60 0.7× 42 490
Christopher Biggs United States 8 316 1.0× 78 0.6× 75 0.7× 66 0.7× 79 0.9× 19 495
Elena Bellan Italy 9 415 1.3× 205 1.7× 230 2.2× 145 1.6× 85 1.0× 16 672
Emmanuelle Tresch‐Bruneel France 11 349 1.1× 105 0.9× 273 2.6× 62 0.7× 163 1.8× 27 490
Jorge Torres‐Mora United States 10 189 0.6× 149 1.2× 154 1.5× 112 1.2× 40 0.4× 38 527
M. M. Van Glabbeke Netherlands 5 480 1.5× 59 0.5× 202 1.9× 175 1.9× 90 1.0× 8 573
William Newman United States 12 204 0.6× 79 0.6× 119 1.1× 71 0.8× 75 0.8× 29 531
Motokiyo Komiyama Japan 13 244 0.7× 98 0.8× 119 1.1× 151 1.6× 41 0.5× 37 471
Strong Lc United States 3 317 1.0× 102 0.8× 200 1.9× 122 1.3× 52 0.6× 4 606
Gamal El-Husseiny Saudi Arabia 12 229 0.7× 75 0.6× 266 2.5× 246 2.7× 78 0.9× 26 678

Countries citing papers authored by Heather Magnan

Since Specialization
Citations

This map shows the geographic impact of Heather Magnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather Magnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather Magnan more than expected).

Fields of papers citing papers by Heather Magnan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather Magnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather Magnan. The network helps show where Heather Magnan may publish in the future.

Co-authorship network of co-authors of Heather Magnan

This figure shows the co-authorship network connecting the top 25 collaborators of Heather Magnan. A scholar is included among the top collaborators of Heather Magnan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather Magnan. Heather Magnan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Tae Min, Charles Ricordel, Jhanelle E. Gray, et al.. (2024). 1302P MET×MET bispecific antibody davutamig (REGN5093) for MET-altered advanced non-small cell lung cancer (aNSCLC): Update from a first-in-human (FIH) study. Annals of Oncology. 35. S828–S829. 2 indexed citations
2.
Ogura, Koichi, Romel Somwar, Julija Hmeljak, et al.. (2020). Therapeutic Potential of NTRK3 Inhibition in Desmoplastic Small Round Cell Tumor. Clinical Cancer Research. 27(4). 1184–1194. 24 indexed citations
3.
Price, Anita P., Debra A. Goldman, William J. Hammond, et al.. (2018). A novel image-based system for risk stratification in patients with desmoplastic small round cell tumor. Journal of Pediatric Surgery. 55(3). 376–380. 7 indexed citations
4.
Mathias, Melissa, Michael V. Ortiz, Heather Magnan, et al.. (2017). A case report of concurrent embryonal rhabdomyosarcoma and diffuse large B-cell lymphoma in an adult without identifiable cancer predisposition. Biomarker Research. 5(1). 7–7. 1 indexed citations
5.
Gavane, Somali, Anita P. Price, Heather Magnan, Sonia Mahajan, & Neeta Pandit‐Taskar. (2017). Multifocal Osteosarcoma. Clinical Nuclear Medicine. 42(4). e202–e206. 8 indexed citations
6.
Ortiz, Michael V., Heather Magnan, Emily K. Slotkin, et al.. (2017). Intracardiac Low-grade Sarcoma Following Treatment for Ewing Sarcoma. Journal of Pediatric Hematology/Oncology. 39(8). e443–e445. 1 indexed citations
7.
Rutkowski, Piotr, Heather Magnan, Alexander J. Chou, & Charlotte Benson. (2017). Treatment of gastrointestinal stromal tumours in paediatric and young adult patients with sunitinib: a multicentre case series. BMC Cancer. 17(1). 717–717. 13 indexed citations
8.
Shukla, Neerav, Juber Patel, Heather Magnan, et al.. (2017). Plasma DNA-Based Molecular Diagnosis, Prognostication, and Monitoring of Patients With EWSR1 Fusion-Positive Sarcomas. JCO Precision Oncology. 2017(1). 1–11. 30 indexed citations
9.
Mora, Jaume, Shakeel Modak, Nai‐Kong V. Cheung, et al.. (2015). Desmoplastic Small Round Cell Tumor 20 Years After its Discovery. Future Oncology. 11(7). 1071–1081. 29 indexed citations
10.
Magnan, Heather, et al.. (2015). Ifosfamide dose-intensification for patients with metastatic Ewing sarcoma. Pediatric Blood & Cancer. 62(4). 594–597. 15 indexed citations
11.
Folkert, Michael R., Michael P. LaQuaglia, Leonard H. Wexler, et al.. (2014). 20-Year Experience With Intraoperative High-Dose-Rate Brachytherapy for Pediatric Sarcoma: Outcomes, Toxicity, and Practice Recommendations. International Journal of Radiation Oncology*Biology*Physics. 90(2). 362–368. 27 indexed citations
12.
Casey, Dana L., Paul A. Meyers, Kaled M. Alektiar, et al.. (2014). Ewing sarcoma in adults treated with modern radiotherapy techniques. Radiotherapy and Oncology. 113(2). 248–253. 12 indexed citations
13.
Ulaner, Gary A., Heather Magnan, John H. Healey, Wolfgang Weber, & Paul A. Meyers. (2014). Is Methylene Diphosphonate Bone Scan Necessary for Initial Staging of Ewing Sarcoma if 18F-FDG PET/CT Is Performed?. American Journal of Roentgenology. 202(4). 859–867. 16 indexed citations
14.
Magnan, Heather, Sara J. Abramson, Anita P. Price, et al.. (2013). Positron Emission Tomography for Response Assessment in Desmoplastic Small Round Cell Tumor. Journal of Pediatric Hematology/Oncology. 35(5). e190–e193. 14 indexed citations
15.
Price, Anita P., Stephen E. Fleming, Michael Sohn, et al.. (2012). Characteristic imaging features of desmoplastic small round cell tumour. Pediatric Radiology. 43(1). 93–102. 42 indexed citations
16.
Desai, Neil, Michael P. LaQuaglia, Kaled M. Alektiar, et al.. (2012). Reduced Toxicity With Intensity Modulated Radiation Therapy (IMRT) for Desmoplastic Small Round Cell Tumor (DSRCT): An Update on the Whole Abdominopelvic Radiation Therapy (WAP-RT) Experience. International Journal of Radiation Oncology*Biology*Physics. 85(1). e67–e72. 51 indexed citations
17.
Araten, David J., Rosario Notaro, Howard T. Thaler, et al.. (2011). Thrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of nine patients and a review of the literature. Haematologica. 97(3). 344–352. 20 indexed citations
18.
Magnan, Heather, Alexander J. Chou, Joanne F. Chou, et al.. (2010). Noninvasive imaging with thallium‐201 scintigraphy may not correlate with survival in patients with osteosarcoma. Cancer. 116(17). 4147–4151. 11 indexed citations
19.
Araten, David J., Rosario Notaro, Nancy A. Kernan, et al.. (2010). Thrombolytic Therapy for Reversal of Thrombosis In Paroxysmal Nocturnal Hemoglobinuria (PNH). Blood. 116(21). 4239–4239. 2 indexed citations
20.
Magnan, Heather, Mark L. Kayton, Donna DiMichele, et al.. (2009). Splenic infarction and subsequent splenic rupture in a patient with paroxysmal nocturnal hemoglobinuria and heparin‐induced thrombocytopenia. Pediatric Blood & Cancer. 53(3). 472–474. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fazilet Öner Dinçbaş Breakdown of academic impact, for papers by Christopher Biggs Breakdown of academic impact, for papers by Elena Bellan Breakdown of academic impact, for papers by Emmanuelle Tresch‐Bruneel Breakdown of academic impact, for papers by Jorge Torres‐Mora Breakdown of academic impact, for papers by M. M. Van Glabbeke Breakdown of academic impact, for papers by William Newman Breakdown of academic impact, for papers by Motokiyo Komiyama Breakdown of academic impact, for papers by Strong Lc Breakdown of academic impact, for papers by Gamal El-Husseiny
Rankless by CCL
2026